From Science Business:
The European Molecular Biology Organisation (EMBO) is taking the unusual step of making the finances of four of its journals public in order to highlight the challenges of transforming subscription or part-subscription journals into fully open access titles.
The analysis covers four of EMBO’s five journals and reveals that, in 2017, their total revenue was almost €6 million [$6.67 million/USD].
Subscriptions generated nearly €4 million of this, with the remaining revenue consisting mainly of article processing charges (APCs), the fees paid by the author, the author’s institution, or their research funder.
The four journals published 706 articles in 2017, of which 495 were research papers and 29 were reviews. The remaining 182 articles were opinion pieces, editorials and news articles.
The cost per article amounted to €6,340, EMBO estimates. But “if the costs for the entire content at EMBO had to be financed only through the APCs for research papers, then the charge for each paper would have to be €9,040 [$10,060/USD],” the report says.
Read the Complete Article (approx. 640 words)
Direct to Primary Source: The Publishing Costs at EMBO (via EMBO)